Mild hypoxia, induced by low-dose cobalt chloride (CoCl2) in C. elegans, significantly extended healthspan — measured as sustained locomotor activity and distance traveled across adulthood — through coordinated upregulation of canonical hypoxia-responsive genes including acs-2, icl-1, adh-1, ftn-1, and ftn-2. Critically, ador-1 knockout worms showed both reduced baseline healthspan and a substantially blunted transcriptional response to CoCl2, implicating the adenosine receptor ADORA2B as a required upstream regulator of this adaptive cascade. GSEA further revealed activation of neuronal plasticity, muscle function, and mitochondrial adaptation pathways alongside ROS pathway downregulation in wild-type animals — a profile absent in mutants.
The finding reframes ADORA2B from a metabolic stress modulator to a master coordinator of hypoxic healthspan programming. In the broader landscape, intermittent hypoxia protocols — including altitude exposure and hypoxic conditioning — have attracted growing interest in human longevity research, but molecular gatekeepers have remained obscure. ADORA2B's human ortholog is druggable, making this mechanistic insight potentially translatable. That said, C. elegans findings face steep extrapolation hurdles: worm adenosine signaling differs substantially from mammalian systems, and healthspan here is defined narrowly by locomotion. The study is observational-mechanistic rather than causal in mammals. Still, identifying a single receptor whose loss ablates multi-pathway hypoxic adaptation represents a genuinely novel node in longevity biology — incremental in organism scope, but potentially paradigm-shifting in identifying adenosinergic signaling as central to hypoxic healthspan extension.
